| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000250365.2 |
AKT inhibitor VIII |
Bladder urothelial carcinoma |
0.011427205 |
Resistant |
| ENSG00000250365.2 |
AKT inhibitor VIII |
Esophageal cancer |
0.001049987 |
Resistant |
| ENSG00000250365.2 |
AKT inhibitor VIII |
Brain lower grade glioma |
0.007977684 |
Resistant |
